Cargando…
Pharmacokinetics, Mass Balance, Excretion, and Tissue Distribution of Plasmalogen Precursor PPI-1011
PPI-1011 is a synthetic plasmalogen precursor in development as a treatment for multiple plasmalogen-deficiency disorders. Previous work has demonstrated the ability of PPI-1011 to augment plasmalogens and its effects in vitro and in vivo, however, the precise uptake and distribution across tissues...
Autores principales: | Smith, Tara, Knudsen, Kaeli J., Ritchie, Shawn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081329/ https://www.ncbi.nlm.nih.gov/pubmed/35547803 http://dx.doi.org/10.3389/fcell.2022.867138 |
Ejemplares similares
-
In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor
por: Wood, Paul L, et al.
Publicado: (2011) -
Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease
por: Wood, Paul L, et al.
Publicado: (2011) -
Lymphatic Absorption of Microbial Plasmalogens in Rats
por: Sato, Nana, et al.
Publicado: (2022) -
Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons
por: Goodenowe, Dayan B., et al.
Publicado: (2022) -
The Potential Role of Bioactive Plasmalogens in Lung Surfactant
por: Zhuo, Ruijiang, et al.
Publicado: (2021)